SYNTHETIC BLOOD INTERNATIONAL INC
10-K405, EX-27, 2000-08-03
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SYNTHETIC BLOOD INTERNATIONAL INC, 10-K405, 2000-08-03
Next: FIRST AMERICAN FINANCIAL CORP, 8-K, 2000-08-03



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM YEAR ENDED
APRIL 30, 2000 SYNTHETIC BLOOD INTERNATIONAL, INC.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               APR-30-2000
<CASH>                                       5,466,391
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,937,456
<PP&E>                                          75,725
<DEPRECIATION>                                  43,994
<TOTAL-ASSETS>                               6,199,651
<CURRENT-LIABILITIES>                          345,440
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       809,073
<OTHER-SE>                                   5,045,138
<TOTAL-LIABILITY-AND-EQUITY>                 6,199,651
<SALES>                                              0
<TOTAL-REVENUES>                                16,141
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               911,598
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,882
<INCOME-PRETAX>                              (911,339)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (911,339)
<EPS-BASIC>                                    ($0.01)
<EPS-DILUTED>                                  ($0.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission